VCAM1 Antikörper (PE-Cy7)
Kurzübersicht für VCAM1 Antikörper (PE-Cy7) (ABIN7674098)
Target
Alle VCAM1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- PE-Cy7 Anti-Mouse CD106 Antibody
-
Aufreinigung
- 0
-
Reinheit
- 0
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Volume per test: 5μL. Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0. 1 % sodium azide, 1 % BSA, pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- VCAM1 (Vascular Cell Adhesion Molecule 1 (VCAM1))
-
Andere Bezeichnung
- CD106
-
Hintergrund
-
Synonyms: CD106|V-CAM 1|VCAM-1|Vascular cell adhesion protein 1|Vcam1
Background: CD106 is a 110 kD glycosylphosphatidylinositol (GPI)-linked transmembrane protein, also known as VCAM-1 and INCAM-110. It is constitutively expressed on bone marrow stromal cells, myeloid progenitors, splenic dendritic cells, activated endothelial cells, as well as some lymphocytes. CD106 expression can be upregulated on endothelial cells by inflammatory cytokines. CD106 is involved in adhesion and acts as a counter-receptor for VLA-4 (α4/β1 integrin) and LPAM-1 (α4/β7 integrin).
-
Molekulargewicht
- 0
-
Gen-ID
- 22329
-
UniProt
- P29533
-
Pathways
- Carbohydrate Homeostasis
Target
-